Red blood cell generation from human induced pluripotent stem cells: perspectives for transfusion medicine.
about
Concise review: stem cell-derived erythrocytes as upcoming players in blood transfusionInduced pluripotent stem cell (iPSCs) and their application in immunotherapyManufacturing blood ex vivo: a futuristic approach to deal with the supply and safety concernsIn-vitro stem cell derived red blood cells for transfusion: are we there yet?Malaria modeling: In vitro stem cells vs in vivo modelsArtificial Blood Substitutes: First Steps on the Long Route to Clinical UtilityEvaluation of Stem Cell-Derived Red Blood Cells as a Transfusion Product Using a Novel Animal ModelNeurons and cardiomyocytes derived from induced pluripotent stem cells as a model for mitochondrial defects in Friedreich's ataxia.Activation of KLF1 Enhances the Differentiation and Maturation of Red Blood Cells from Human Pluripotent Stem Cells.Erythropoiesis from human embryonic stem cells through erythropoietin-independent AKT signaling.Qualitative and quantitative comparison of the proteome of erythroid cells differentiated from human iPSCs and adult erythroid cells by multiplex TMT labelling and nanoLC-MS/MSGeneration of red blood cells in vitro: monitoring the process for improved efficiency.Transcriptome dynamics during human erythroid differentiation and development.Proof of principle for transfusion of in vitro-generated red blood cells.Human induced pluripotent stem cells can reach complete terminal maturation: in vivo and in vitro evidence in the erythropoietic differentiation model.Induction of adult levels of β-globin in human erythroid cells that intrinsically express embryonic or fetal globin by transduction with KLF1 and BCL11A-XLEstablishment of immortalized human erythroid progenitor cell lines able to produce enucleated red blood cells.Large-scale production of red blood cells from stem cells: what are the technical challenges ahead?Erythroid differentiation of human induced pluripotent stem cells is independent of donor cell type of origin.Generation of red blood cells from human induced pluripotent stem cellsHuman induced pluripotent stem cell derived erythroblasts can undergo definitive erythropoiesis and co-express gamma and beta globins.Site-specific gene correction of a point mutation in human iPS cells derived from an adult patient with sickle cell disease.Recurrent genomic instability of chromosome 1q in neural derivatives of human embryonic stem cells.A Systems Approach Identifies Essential FOXO3 Functions at Key Steps of Terminal Erythropoiesis.Stem cell-derived erythrocytes as upcoming players in blood transfusion.Alternative blood products and clinical needs in transfusion medicineDistinct gene expression program dynamics during erythropoiesis from human induced pluripotent stem cells compared with adult and cord blood progenitors.Trisomy 21-associated defects in human primitive hematopoiesis revealed through induced pluripotent stem cellsEffect of Induced Pluripotent Stem Cell Technology in Blood BankingConcise Review: early embryonic erythropoiesis: not so primitive after all.Novel, high-yield red blood cell production methods from CD34-positive cells derived from human embryonic stem, yolk sac, fetal liver, cord blood, and peripheral bloodβ-Globin-Expressing Definitive Erythroid Progenitor Cells Generated from Embryonic and Induced Pluripotent Stem Cell-Derived Sacs.Enforced Expression of HOXB4 in Human Embryonic Stem Cells Enhances the Production of Hematopoietic Progenitors but Has No Effect on the Maturation of Red Blood Cells.Generation of glycosylphosphatidylinositol anchor protein-deficient blood cells from human induced pluripotent stem cellsExtensive ex vivo expansion of functional human erythroid precursors established from umbilical cord blood cells by defined factors.Mononuclear cells from a rare blood donor, after freezing under good manufacturing practice conditions, generate red blood cells that recapitulate the rare blood phenotypeConcise review: drug discovery in the age of the induced pluripotent stem cell.Erythroblast enucleation.Generation and characterization of erythroid cells from human embryonic stem cells and induced pluripotent stem cells: an overview.Generation of mature hematopoietic cells from human pluripotent stem cells.
P2860
Q26825749-4B603120-9688-4C41-9068-2F4CDA6ADACCQ26996540-A8D2F48F-E564-4C23-AB6D-3BB49A6784D5Q27007110-42479611-82AE-4F13-AD9E-C6B77932FF91Q27022575-F9D255A3-BC57-40CA-B3E5-A13CDFA36595Q28071293-39F7CC11-42E6-400D-B180-63E06141FB11Q28075789-EEDB3AFC-955B-47AE-B284-33C89D65E648Q28554997-2E0CA714-7499-441C-8F0E-7D6C82CF3B73Q30539140-7C687BB9-7EB6-4405-8943-ADB4E36F4565Q33578349-692FFE99-AE0D-49C7-AAAB-42BF8261ABCCQ33680486-117516BD-F20F-42B8-8A12-A590A4CD6213Q33895201-692192A4-59E0-46EC-B27D-5F7CCBD82C33Q34109122-54E9B95A-007D-4EF1-86D2-0956AC604945Q34117785-80900157-8215-459F-8B68-64227DEF1C9DQ34212764-DADA184B-4B76-40A0-9D68-67A7E1EB761BQ34284032-B8E952F4-6866-4C1E-AD0E-E2F412E1462EQ34463668-7FC6CC08-1794-4F9F-A6A3-B800F1C7F023Q34637983-4EA49EDC-FDF8-4CC3-9140-9D2A400A3C81Q34658807-8FF4B2EA-6189-40E6-BB13-FC1E1A52C5D4Q34797997-DFFD522D-D079-4D3E-8857-C494782CB02BQ35179358-16227D70-AC50-4CA4-AFFC-E66F802241DEQ35221675-706C3C79-A055-480D-B6CB-E6E7ABE44900Q35525329-97CFD307-592B-472A-A9C8-0B41B7DB2822Q35698880-A4AFD362-EF59-47E4-8809-4F12D56DE64AQ35801800-12051168-6EB3-4DBC-8CC4-6B773153805BQ35897250-8CA4587B-7F6B-49B7-83A6-723E0592992FQ35915095-34554F3C-0B16-4DAD-BBE8-65283D9097FAQ36171095-7CB08893-2310-4A66-A0A7-D8DBC37F44EDQ36378400-A02D241F-EB62-4AE3-B20C-82203B84BB2DQ36728573-804760F1-8795-4C22-8D35-9139BF9E1FDEQ36798182-356B4052-E056-4A2E-B66C-ADF419ABB7E8Q36861652-3D65B5AC-B9B3-4D23-98B0-FD16AE072834Q36968324-7E09F250-8846-46CB-909E-4D73B3CBE3E3Q37111916-9665C510-2065-4005-B76F-4A345129AADFQ37255037-60E0C888-9E55-42A3-A652-37ED70257B2DQ37562037-4554E5A5-B82D-44D9-ADA9-74EE7BA59902Q37617110-D48D46BE-D417-4943-BADD-AB0BF0412A07Q37680999-85F91E25-5D7E-4DE0-A555-EAB7C0CA35F7Q37946896-8EC445E9-6412-45E8-B127-8271EBC2E799Q37963881-4306FE4B-A72A-4EBA-8076-853818166CD1Q38014778-9DA76018-F379-46D2-85C5-419A8AC87FC1
P2860
Red blood cell generation from human induced pluripotent stem cells: perspectives for transfusion medicine.
description
2010 nî lūn-bûn
@nan
2010 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Red blood cell generation from ...... ives for transfusion medicine.
@ast
Red blood cell generation from ...... ives for transfusion medicine.
@en
Red blood cell generation from ...... ives for transfusion medicine.
@nl
type
label
Red blood cell generation from ...... ives for transfusion medicine.
@ast
Red blood cell generation from ...... ives for transfusion medicine.
@en
Red blood cell generation from ...... ives for transfusion medicine.
@nl
prefLabel
Red blood cell generation from ...... ives for transfusion medicine.
@ast
Red blood cell generation from ...... ives for transfusion medicine.
@en
Red blood cell generation from ...... ives for transfusion medicine.
@nl
P2093
P2860
P1433
P1476
Red blood cell generation from ...... tives for transfusion medicine
@en
P2093
Alain Francina
Christelle Mazurier
Georges Andreu
Hélène Lapillonne
Isabelle Zanella-Cleon
Ladan Kobari
Laurent Kiger
Marie Wattenhofer-Donzé
Marie-Catherine Giarratana
P2860
P304
P356
10.3324/HAEMATOL.2010.023556
P577
2010-05-21T00:00:00Z